Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Kintor Pharma Announces 2021 Business Progress and Annual Results 2022-03-26 01:23
Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG 2022-03-25 21:24
Abcam the most awarded company at 2022 industry awards 2022-03-25 20:40
Modern Chinese Medicine Announces Year 2021 Annual Results 2022-03-25 10:39
Harbour BioMed Reports Full Year 2021 Financial Results: Empower Value Creation with Global Innovation Capabilities 2022-03-25 10:22
New clinical trial collaboration for Cu-64 SAR-bisPSMA in prostate cancer 2022-03-24 21:08
Insilico Medicine Announces Strategic Collaboration with EQRx to Jointly Advance AI-driven Drug Discovery, Development and Commercialization for Multiple Targets 2022-03-24 21:00
Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care 2022-03-24 07:00
Fosun International Announces 2021 Annual Results: Total Revenue Increased by 18% to RMB161.29 Billion, Striving to Pursue Steady and Sustainable Development 2022-03-23 23:01
Telix Advances Development of Glioblastoma Therapy Program 2022-03-23 10:16
Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India 2022-03-23 09:31
InnoCare Releases 2021 Annual Results and Business Highlights 2022-03-23 08:08
Brii Biosciences Provides Corporate Update and Reports Full Year 2021 Financial Results 2022-03-23 07:20
Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively 2022-03-23 06:53
WuXi Biologics Achieved Record Growth and Profitability in 2021 2022-03-23 00:38
Jacobio Announces Annual Results of 2021, R&D Investment Increases 83% 2022-03-22 22:50
NIBIOHN Identifies Tissue-specific Exosome Marker Candidates from Blood 2022-03-22 14:00
Ascentage Pharma's MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Rare Pediatric Disease Designation by the US FDA for the Treatment of Neuroblastoma 2022-03-22 09:15
Transcenta Announces Global Clinical Collaboration with Bristol Myers Squibb to Evaluate TST001 in Combination with Opdivo® in Patients with Locally Advanced or Metastatic Gastric / Gastroesophageal Junction Cancer 2022-03-22 08:19
Cali Biosciences Announces Successful Results in Phase IIb Study of Long-Acting Ropivacaine (CPL-01) for Non-Opioid Treatment of Post-Operative Pain 2022-03-22 00:00
1 195 196 197 198 199 423